Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHA save search
Innate Pharma to Participate in Upcoming Investor Conference - June 23, 2022
Published: 2022-06-23 (Crawled : 07:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.32%
H: 1.34%
C: 1.31%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.15%
H: 3.02%
C: -1.13%
pharma conference
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: -0.32%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.65%
H: 0.63%
C: 0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.96%
H: 0.98%
C: -1.15%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
iph5201 pharma cancer phase 2
Innate Pharma to Participate in Upcoming Investor Conferences - May 11, 2022
Published: 2022-05-11 (Crawled : 09:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.55%
H: 2.32%
C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 5.34%
H: 1.75%
C: -1.4%
pharma
Innate Pharma Reports First Quarter 2022 Financial Results and Business Update
Published: 2022-05-10 (Crawled : 07:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -0.37%
H: 2.23%
C: 0.93%
pharma results
Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update
Published: 2022-05-03 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.59%
H: 0.96%
C: -0.04%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.4%
H: 1.38%
C: -0.35%
pharma conference
Innate Pharma: First Patient Dosed in Monalizumab Phase 3 Lung Cancer Clinical Trial Triggers $50M Payment From AstraZeneca
Published: 2022-04-29 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 5.98%
H: 1.44%
C: -0.42%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.93%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 11.11%
H: 3.67%
C: -4.33%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.53%
H: 2.37%
C: 0.26%
trial payment cancer phase 3
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 20, 2022
Published: 2022-04-08 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.49%
H: 1.22%
C: 0.47%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 3.55%
H: 0.0%
C: -1.87%
pharma
Innate Pharma Files Its 2021 Universal Registration Document (Document d’enregistrement universel) and 2021 Annual Report on Form 20-F
Published: 2022-04-05 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.57%
H: 1.02%
C: 0.31%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.64%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -3.43%
pharma report
Innate Pharma Reports Full Year 2021 Financial Results and Business Update
Published: 2022-03-24 (Crawled : 08:00) - biospace.com/
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: -0.98%
H: 1.17%
C: 0.78%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.27%
H: 0.98%
C: 0.93%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.17%
results pharma
Innate Pharma Announces Conference Call and Webcast for Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 2.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.51%
H: 2.38%
C: 2.08%
financial results conference results pharma
Innate Pharma to Participate in Upcoming Investor Conferences - Feb 04, 2022
Published: 2022-02-04 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.02%
H: 0.52%
C: 0.0%
conference pharma
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2022
Published: 2022-01-24 (Crawled : 12:30) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: -10.12%
H: 1.05%
C: 1.05%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: -1.88%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -3.36%
H: 3.08%
C: 2.84%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.45%
H: 0.18%
C: -0.02%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.85%
H: 0.26%
C: -5.36%
pharma
Innate Pharma Obtains €28.7m in Non-Dilutive Financing in the Form of State Guaranteed Loans
Published: 2022-01-05 (Crawled : 12:00) - biospace.com/
BNPQF | $68.558 -13.4% 400
|
Finance
|
| O: 2.94%
H: 0.0%
C: -3.23%
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: 1.62%
H: 0.17%
C: -1.98%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 3.0%
H: 1.25%
C: -0.42%
pharma
Innate Pharma to Participate in Upcoming Investor Conferences - Jan 04, 2022
Published: 2022-01-04 (Crawled : 10:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -5.25%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.03%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: -2.51%
conference pharma
Innate Pharma: First Patient Dosed in IPH6101/SAR443579 Phase 1/2 Clinical Trial in Various Blood Cancers
Published: 2021-12-16 (Crawled : 09:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -5.02%
H: 5.6%
C: 0.96%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 2.6%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -1.27%
H: 1.68%
C: 0.5%
iph6101 blood trial phase 1 cancer phase 2
Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress
Published: 2021-12-09 (Crawled : 11:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.09%
H: 0.32%
C: -0.26%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.2%
H: 1.6%
C: -2.8%
cancer
Innate Pharma to Present Monalizumab Data at ESMO Immuno-Oncology 2021 Congress
Published: 2021-12-02 (Crawled : 12:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: -4.47%
H: 0.0%
C: -0.61%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.63%
H: 0.64%
C: 0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -3.56%
H: 1.03%
C: -2.67%
pharma
Innate Pharma to Participate in the Evercore ISI 4th Annual HealthConX Virtual Conference
Published: 2021-11-24 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.48%
H: 1.68%
C: 0.42%
conference pharma
Innate Pharma Third Quarter 2021 Report
Published: 2021-11-16 (Crawled : 11:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 4.0%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.34%
H: 0.84%
C: 0.26%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.31%
H: 0.75%
C: -0.38%
pharma
Innate Pharma Announces Conference Call and Webcast for Q3 2021 Business Update
Published: 2021-11-09 (Crawled : 09:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.85%
H: 0.18%
C: -1.99%
conference pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.